{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T16:36:20Z","timestamp":1775147780406,"version":"3.50.1"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T00:00:00Z","timestamp":1598313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"DOI":"10.3389\/fpsyt.2020.00862","type":"journal-article","created":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T04:38:41Z","timestamp":1598330321000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Reinforcing Effects of the Synthetic Cathinone \u03b1-Pyrrolidinopropiophenone (\u03b1-PPP) in a Repeated Extended Access Binge Paradigm"],"prefix":"10.3389","volume":"11","author":[{"given":"Erin K.","family":"Nagy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula F.","family":"Overby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Foster","family":"Olive","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,8,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.8b00147","article-title":"DARK classics in chemical neuroscience: Cathinone-derived psychostimulants","volume":"9","author":"Simmons","year":"2018","journal-title":"ACS Chem Neurosci"},{"key":"B2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.2174\/1570159X13666141210224137","article-title":"Synthetic cathinones: a new public health problem","volume":"13","author":"Karila","year":"2015","journal-title":"Curr Neuropharmacol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s11419-016-0353-6","article-title":"a-Pyrrolidinophenones: a new wave of designer cathinones","volume":"35","author":"Zawilska","year":"2017","journal-title":"Forensic Toxicol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2012.02145.x","article-title":"Pharmacological characterization of designer cathinones in vitro","volume":"168","author":"Simmler","year":"2013","journal-title":"Br J Pharmacol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2014.12.012","article-title":"Monoamine transporter and receptor interaction profiles of novel psychoactive substances: para-halogenated amphetamines and pyrovalerone cathinones","volume":"25","author":"Rickli","year":"2015","journal-title":"Eur Neuropsychopharmacol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/7854_2016_53","article-title":"Neuropharmacology of 3,4-methylenedioxypyrovalerone (MDPV), its metabolites, and related analogs","volume":"32","author":"Baumann","year":"2017","journal-title":"Curr Top Behav Neurosci"},{"key":"B7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1124\/jpet.116.236349","article-title":"Structure-activity relationships of substituted cathinones, with transporter binding, uptake, and release","volume":"360","author":"Eshleman","year":"2017","journal-title":"J Pharmacol Exp Ther"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2012.204","article-title":"Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive \u2018bath salts\u2019 products","volume":"38","author":"Baumann","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/FBP.0b013e328364166d","article-title":"Locomotor stimulant and discriminative stimulus effects of \u2018bath salt\u2019 cathinones","volume":"24","author":"Gatch","year":"2013","journal-title":"Behav Pharmacol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-014-3755-3","article-title":"Discriminative and locomotor effects of five synthetic cathinones in rats and mice","volume":"232","author":"Gatch","year":"2015","journal-title":"Psychopharmacology"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-017-4562-4","article-title":"Locomotor activity and discriminative stimulus effects of a novel series of synthetic cathinone analogs in mice and rats","volume":"234","author":"Gatch","year":"2017","journal-title":"Psychopharmacol (Berl)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1177\/0269881120914213","article-title":"Methylenedioxymethamphetamine-like discriminative stimulus effects of pyrrolidinyl cathinones in rats","volume":"34","author":"Gatch","year":"2020","journal-title":"J Psychopharmacol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1369-1600.2012.00474.x","article-title":"Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV)","volume":"19","author":"Watterson","year":"2014","journal-title":"Addict Biol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2013.04.003","article-title":"The novel recreational drug 3,4-methylenedioxypyrovalerone (MDPV) is a potent psychomotor stimulant: self-administration and locomotor activity in rats","volume":"71","author":"Aarde","year":"2013","journal-title":"Neuropharmacology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.neuropharm.2017.08.018","article-title":"Relative reinforcing effects of second-generation synthetic cathinones: Acquisition of self-administration and fixed ratio dose-response curves in rats","volume":"134","author":"Gannon","year":"2018","journal-title":"Neuropharmacology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2013.06.016","article-title":"Clinical and pharmacological aspects of bath salt use: a review of the literature and case reports","volume":"132","author":"Miotto","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2015.08.028","article-title":"Self-reported use of novel psychoactive substances in a US nationally representative survey: prevalence, correlates, and a call for new survey methods to prevent underreporting","volume":"156","author":"Palamar","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"B18","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.neuropharm.2017.11.034","article-title":"Neurocognitive dysfunction following repeated binge-like self-administration of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV)","volume":"134","author":"Sewalia","year":"2018","journal-title":"Neuropharmacology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2013.08.005","article-title":"96-hour methamphetamine self-administration in male and female rats: A novel model of human methamphetamine addiction","volume":"111","author":"Cornett","year":"2013","journal-title":"Pharmacol Biochem Behav"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s002130050584","article-title":"Withdrawal from a self-administered or non-contingent cocaine binge: differences in ultrasonic distress vocalizations in rats","volume":"136","author":"Mutschler","year":"1998","journal-title":"Psychopharmacology"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1037\/a0016498","article-title":"Yoked delivery of cocaine is aversive and protects against the motivation for drug in rats","volume":"123","author":"Twining","year":"2009","journal-title":"Behav Neurosci"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.5694\/mja13.00203","article-title":"Death due to intravenous use of \u03b1-pyrrolidinopentiophenone","volume":"201","author":"Sellors","year":"2014","journal-title":"Med J Aust"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-018-5044-z","article-title":"Effects of the second-generation \u201cbath salt\u201d cathinone alpha-pyrrolidinopropiophenone (\u03b1-PPP) on behavior and monoamine neurochemistry in male mice","volume":"236","author":"Ray","year":"2019","journal-title":"Psychopharmacol (Berl)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2014.02.016","article-title":"Pharmacology of novel synthetic stimulants structurally related to the \u201cbath salts\u201d constituent 3,4-methylenedioxypyrovalerone (MDPV)","volume":"87","author":"Marusich","year":"2014","journal-title":"Neuropharmacology"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-018-0209-3","article-title":"The abuse-related effects of pyrrolidine-containing cathinones are related to their potency and selectivity to inhibit the dopamine transporter","volume":"43","author":"Gannon","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/dta.2582","article-title":"The synthetic cathinone psychostimulant \u03b1-PPP antagonizes serotonin 5-HT2A receptors: In vitro and in vivo evidence","volume":"11","author":"Chen","year":"2019","journal-title":"Drug Test Anal"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-3057(98)00240-8","article-title":"5-HT2 receptor antagonism reduces hyperactivity induced by amphetamine, cocaine, and MK-801 but not D1 agonist c-APB","volume":"63","author":"O\u2019Neill","year":"1999","journal-title":"Pharmacol Biochem Behav"},{"key":"B28","article-title":"Antagonism of 5-hydroxytryptamine2a receptors attenuates the behavioral effects of cocaine in rats","volume":"297","author":"McMahon","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1523\/jneurosci.1437-13.2013","article-title":"Serotonin 2A receptors differentially contribute to abuse-related effects of cocaine and cocaine-induced nigrostriatal and mesolimbic dopamine overflow in nonhuman primates","volume":"33","author":"Murnane","year":"2013","journal-title":"J Neurosci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2003.07.008","article-title":"Metabolism of the new designer drug alpha-pyrrolidinopropiophenone (PPP) and the toxicological detection of PPP and 4\u2019-methyl-alpha-pyrrolidinopropiophenone (MPPP) studied in rat urine using gas chromatography-mass spectrometry","volume":"796","author":"Springer","year":"2003","journal-title":"J Chromatogr B Analyt Technol BioMed Life Sci"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1021\/jm050797a","article-title":"1-(4-methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (pyrovalerone) analogues: a promising class of monoamine uptake inhibitors","volume":"49","author":"Meltzer","year":"2006","journal-title":"J Med Chem"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2020.00862\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T04:38:43Z","timestamp":1598330323000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2020.00862\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,25]]},"references-count":31,"alternative-id":["10.3389\/fpsyt.2020.00862"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2020.00862","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,25]]},"article-number":"862"}}